Cephalon CEO checks out on medical leave

Cephalon CEO and founder Frank Baldino, Jr. (photo) will take an immediate leave of absence for medical reasons, leaving COO J. Kevin Buchi in charge until later this year. In a statement, the company declined to provide further information about the cause of Baldino's absence. Cephalon release | Report

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.